Literature DB >> 33763046

Phage-Mediated Control of Flavobacterium psychrophilum in Aquaculture: In vivo Experiments to Compare Delivery Methods.

Valentina Laura Donati1, Inger Dalsgaard1, Krister Sundell2, Daniel Castillo3, Mériem Er-Rafik4, Jason Clark5, Tom Wiklund2, Mathias Middelboe3, Lone Madsen1.   

Abstract

Phage-based approaches have gained increasing interest as sustainable alternative strategies to antibiotic treatment or as prophylactic measures against disease outbreaks in aquaculture. The potential of three methods (oral, bath, and injection) for delivering a two-component phage mixture to rainbow trout fry for controlling Flavobacterium psychrophilum infections and reduce fish mortality was investigated using bacteriophages FpV4 and FPSV-D22. For the oral administration experiment, bacteriophages were applied on feed pellets by spraying (1.6 × 108 PFU g-1) or by irreversible immobilization (8.3 × 107 PFU g-1), using the corona discharge technology (Fixed Phage Ltd.). The fish showed normal growth for every group and no mortality was observed prior to infection as well as in control groups during the infection. Constant detection of phages in the intestine (∼103 PFU mg-1) and more sporadic occurrence in kidney, spleen, and brain was observed. When fish were exposed to F. psychrophilum, no significant effect on fish survival, nor a direct impact on the number of phages in the sampled organs, were detected. Similarly, no significant increase in fish survival was detected when phages were delivered by bath (1st and 2nd bath: ∼106 PFU ml-1; 3rd bath: ∼105 PFU ml-1). However, when phages FpV4 and FPSV-D22 (1.7 × 108 PFU fish-1) were administered by intraperitoneal injection 3 days after the bacterial challenge, the final percent survival observed in the group injected with bacteriophages FpV4 and FPSV-D22 (80.0%) was significantly higher than in the control group (56.7%). The work demonstrates the delivery of phages to fish organs by oral administration, but also suggests that higher phage dosages than the tested ones may be needed on feed pellets to offer fish an adequate protection against F. psychrophilum infections.
Copyright © 2021 Donati, Dalsgaard, Sundell, Castillo, Er-Rafik, Clark, Wiklund, Middelboe and Madsen.

Entities:  

Keywords:  Flavobacterium psychrophilum; bacteriophages; phage-therapy; rainbow trout fry (Oncorhynchus mykiss); rainbow trout fry syndrome (RTFS)

Year:  2021        PMID: 33763046      PMCID: PMC7983945          DOI: 10.3389/fmicb.2021.628309

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  5 in total

Review 1.  Bacteriophage therapy in aquaculture: current status and future challenges.

Authors:  Ruyin Liu; Ganghua Han; Zong Li; Shujuan Cun; Bin Hao; Jianping Zhang; Xinchun Liu
Journal:  Folia Microbiol (Praha)       Date:  2022-03-19       Impact factor: 2.629

Review 2.  In Vivo Bacteriophages' Application for the Prevention and Therapy of Aquaculture Animals-Chosen Aspects.

Authors:  Patrycja Schulz; Joanna Pajdak-Czaus; Andrzej Krzysztof Siwicki
Journal:  Animals (Basel)       Date:  2022-05-10       Impact factor: 3.231

3.  The Gut Microbiota of Healthy and Flavobacterium psychrophilum-Infected Rainbow Trout Fry Is Shaped by Antibiotics and Phage Therapies.

Authors:  Valentina Laura Donati; Lone Madsen; Mathias Middelboe; Mikael Lenz Strube; Inger Dalsgaard
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

4.  Interactions between Rainbow Trout Eyed Eggs and Flavobacterium spp. Using a Bath Challenge Model: Preliminary Evaluation of Bacteriophages as Pathogen Control Agents.

Authors:  Valentina L Donati; Inger Dalsgaard; Anniina Runtuvuori-Salmela; Heidi Kunttu; Johanna Jørgensen; Daniel Castillo; Lotta-Riina Sundberg; Mathias Middelboe; Lone Madsen
Journal:  Microorganisms       Date:  2021-04-30

5.  First Characterization of a Hafnia Phage Reveals Extraordinarily Large Burst Size and Unusual Plaque Polymorphism.

Authors:  Lingting Pan; Dengfeng Li; Zhitong Sun; Wei Lin; Binxin Hong; Weinan Qin; Lihua Xu; Wencai Liu; Qin Zhou; Fei Wang; Ruqian Cai; Minhua Qian; Yigang Tong
Journal:  Front Microbiol       Date:  2022-02-08       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.